|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Dipyridamole#Warnings]] |
| {{Dipyridamole}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Warnings And Precautions==
| |
| | |
| ===General===
| |
| | |
| '''Coronary Artery Disease''': Dipyridamole has a vasodilatory effect and should be used with caution in patients with severe coronary artery disease (e.g., [[unstable angina]] or recently sustained [[myocardial infarction]]). Chest pain may be aggravated in patients with underlying coronary artery disease who are receiving dipyridamole.
| |
| | |
| '''Hepatic Insufficiency''': Elevations of hepatic enzymes and hepatic failure have been reported in association with dipyridamole administration.
| |
| | |
| '''Hypotension''': Dipyridamole should be used with caution in patients with [[hypotension]] since it can produce peripheral vasodilation.
| |
| | |
| ===Laboratory Tests===
| |
| | |
| Dipyridamole has been associated with elevated hepatic enzymes.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PERSANTINE (DIPYRIDAMOLE) TABLET, COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca68879c-0214-4d7c-93b0-bdaf8ef23f8e | publisher = | date = | accessdate = 7 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Antiplatelet drugs]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |